Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Promotion of Regular Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in Long-stay ICU Patients. A Multicenter, Phase II, Sham-controlled, Randomized Trial. The PROPEL Study

NCT02515123 is registered in ClinicalTrials.gov with E-Motion Medical Ltd. as lead sponsor.

NCT NCT02515123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02515123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Promotion of Regular Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in Long-stay ICU Patients. A Multicenter, Phase II, Sham-controlled, Randomized Trial. The PROPEL Study
Lead sponsor
E-Motion Medical Ltd.
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2016
Completion date
July 4, 2019
Enrollment
158 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill, malnutrition